Availability and use of rapid diagnostic tests for the management of acute childhood infections in Europe: A cross-sectional survey of paediatricians.
作者:
Juan Emmanuel,Dewez [1]
;
Lucy,Pembrey [2]
;
Ruud G,Nijman [3]
;
Stefano,Del Torso [4]
;
Zachi,Grossman [5]
;
Adamos,Hadjipanayis [6]
;
Diego,Van Esso [7]
;
Emma,Lim [8]
;
Marieke,Emonts [9]
;
James,Burns [2]
;
Christèle,Gras-LeGuen [10]
;
Daniela,Kohlfuerst [11]
;
Hans Jürgen,Dornbusch [12]
;
Karen,Brengel-Pesce [13]
;
Francois,Mallet [13]
;
Ulrich,von Both [14]
;
Maria,Tsolia [15]
;
Irini,Eleftheriou [15]
;
Dace,Zavadska [16]
;
Ronald,de Groot [17]
;
Michiel,van der Flier [18]
;
Henriëtte,Moll [19]
;
Nienke,Hagedoorn [20]
;
Dorine,Borensztajn [20]
;
Rianne,Oostenbrink [21]
;
Taco,Kuijpers [22]
;
Marko,Pokorn [23]
;
Katarina,Vincek [23]
;
Federico,Martinón-Torres [24]
;
Irene,Rivero [24]
;
Philipp,Agyeman [25]
;
Enitan D,Carrol [26]
;
Stéphane,Paulus [27]
;
Aubrey,Cunnington [28]
;
Jethro,Herberg [28]
;
Michael,Levin [28]
;
Aida,Mujkić [29]
;
Karin,Geitmann [30]
;
Liviana,Da Dalt [31]
;
Arūnas,Valiulis [32]
;
Risto,Lapatto [33]
;
Garyfallia,Syridou [34]
;
Péter,Altorjai [35]
;
Paul,Torpiano [36]
;
Ketil,Størdal [37]
;
Károly,Illy [38]
;
Artur,Mazur [39]
;
Mateja Vintar,Spreitzer [40]
;
Joana,Rios [41]
;
Corinne,Wyder [42]
;
Ivanna,Romankevych [43]
;
Romain,Basmaci [44]
;
Salvador,Ibanez-Mico [45]
;
Shunmay,Yeung [46]
作者单位:
Clinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom.;Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).
[1]
Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom.
[2]
Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Department of Infectious Diseases, Section of Paediatric Infectious Diseases, Imperial College London, London, United Kingdom.;Research in European Paediatric Emergency Medicine (REPEM).
[3]
ChildCare WorldWide, Padova, Italy.;European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).
[4]
European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Adelson School of Medicine, Ariel University, Ariel, Israel.;Pediatric Clinic, Maccabi Healthcare Services, Tel Aviv, Israel.
[5]
European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Paediatric Department, Larnaca General Hospital, Larnaca, Cyprus.;Medical School, European University Cyprus, Nicosia, Cyprus.
[6]
European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Primary Care Paediatrician, Health Care Centre Pere Grau, Barcelona, Spain.
[7]
Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Great North Children's Hospital, Paediatric Immunology, Infectious Diseases & Allergy, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.;Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
[8]
Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Great North Children's Hospital, Paediatric Immunology, Infectious Diseases & Allergy, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.;Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
[9]
Centre d'Investigation Clinique CIC1413, INSERM-Nantes University Hospital, Nantes, France.
[10]
Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Medical University of Graz, Graz, Austria.
[11]
European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Medical University of Graz, Graz, Austria.
[12]
Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;BioMérieux, Lyon, France.
[13]
Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;University Hospital, Ludwig Maximilians University (LMU), Munich, Germany.
[14]
Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;P. and A. Kyriakou Children's Hospital, Athens, Greece.
[15]
Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Children Clinical University Hospital, Riga, Latvia.
[16]
Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Radboud University Medical Center, Nijmegen, the Netherlands.
[17]
Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands.
[18]
Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Research in European Paediatric Emergency Medicine (REPEM).;Department of General Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.
[19]
Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Department of General Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.
[20]
Research in European Paediatric Emergency Medicine (REPEM).;Department of General Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.
[21]
Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Amsterdam University Medical Center, Amsterdam, the Netherlands.
[22]
Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Department of Infectious Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia.
[23]
Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.
[24]
Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Bern University Hospital, University of Bern, Bern, Switzerland.
[25]
Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Alder Hey Children's Hospital, Liverpool, United Kingdom.
[26]
Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Department of Paediatrics, Oxford Vaccine Group, University of Oxford, Oxford, United Kingdom.
[27]
Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Department of Infectious Diseases, Section of Paediatric Infectious Diseases, Imperial College London, London, United Kingdom.
[28]
European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;University of Zagreb, School of Medicine, Andrija Štampar School of Public Health, Zagreb, Croatia.
[29]
European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Primary Care Paediatrician, BVKJ, Hagen, Germany.
[30]
Research in European Paediatric Emergency Medicine (REPEM).;Department of Woman's and Child's Health Padova University Hospital, Padua, Italy.
[31]
European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Vilnius University Medical Faculty, Institute of Clinical Medicine, Clinic of Children's Diseases, Vilnius, Lithuania.
[32]
European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Department of Paediatrics, Helsinki University Hospital, Helsinki, Finland.
[33]
European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Attiko University Hospital, Chaidari, Greece.
[34]
European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Association of Hungarian Primary Care Paediatricians, Budapest, Hungary.
[35]
European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Department of Paediatrics and Adolescent Health at Mater Dei Hospital, Valletta, Malta.
[36]
European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Paediatric Research Institute, University of Oslo, Oslo, Norway.
[37]
European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Dutch Society of Paediatrics NVK, Utrecht, the Netherlands.
[38]
European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Medical College of Rzeszow University, Rzeszów, Poland.
[39]
European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Zdravstveni dom Domžale, Slovenian Paediatric Society, Burnaby, Slovenia.
[40]
European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Hospital Beatriz Ângelo, Loures, Portugal.
[41]
European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Kinderärzte KurWerk, Burgdorf, Switzerland.
[42]
European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Ukrainian Academy of Pediatric Specialties, Ukraine.
[43]
Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Service de Pédiatrie-Urgences, AP-HP, Hôpital Louis-Mourier, Colombes, France.
[44]
Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.
[45]
Clinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom.;Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Department of Paediatrics, St Mary's Imperial College Hospital, London, United Kingdom.
[46]
DOI
10.1371/journal.pone.0275336
PMID
36538525
发布时间
2024-09-09
- 浏览0

PloS one
PloS one
e0275336页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文